Microplastics: What We Know So Far
Microplastics have moved from an environmental talking point to a human health concern, and the conversation is growing for good reason. Over the past few years, research has shifted from asking if microplastics enter the human body to documenting where they are showing up.
While working through the literature, the most consistent theme is this:
we can now detect microplastics in human tissue, but we are still learning what that means for our long-term health. The research isn’t conclusive — but it’s evolving quickly.
Let’s break down what we do know today.
What Are Microplastics?
Microplastics are tiny plastic particles less than 5 mm in size.
They come from synthetic clothing fibers, food packaging, water bottles, dust in the air, cosmetics, household items — essentially, daily life.
The two primary ways we absorb them are:
• Inhalation from airborne particles
• Ingestion through food and water
Their size varies, and smaller nano-scale fragments may move more deeply into biological systems, which is where research becomes more concerning.
Where Have Microplastics Been Found in the Human Body?
A review of 26 studies reported microplastic particles in 8 of 12 human organ systems, including:
• Lungs
• Liver
• Kidneys
• Gastrointestinal tract
• Spleen
• Reproductive tissues
• Breast milk
• Brain tissue (post-mortem)
One surprising finding involved brain samples, which contained nanoscale, shard-like fragments primarily composed of polyethylene. Another noted microplastics in the spleen, though researchers couldn’t determine if they were contributing to dysfunction.
The takeaway from this phase of research is not impact — it’s confirmation of presence.
Potential Biological Effects Being Studied
While we don’t have causation, studies are exploring how microplastics may interact with the body:
Inflammation + immune activation
-Microplastics can trigger immune responses when taken up by cells.
Oxidative stress
-Some studies note increased reactive oxygen species and redox imbalance.
Barrier penetration + tissue disruption
-Particles, especially nanosized ones, may cross gut and lung barriers, causing micro-injury.
Chemical carriers
-Microplastics can bind heavy metals, plasticizers, and pollutants, potentially amplifying toxicity.
At this stage, these findings represent suspected mechanisms, not confirmed outcomes. The clinical impact in humans remains unclear.
Where Research Is Still Limited
This is where confusion often comes in — and where we need patience with the science.
Current gaps include:
• Few long-term human studies
• No standardized exposure measurement
• Limited clinical outcome data
• Associations without proven causation
Research is expanding, but we are early. We know microplastics are present, but we do not yet know the downstream effects over years of exposure.
Final Thoughts
Microplastics are no longer theoretical. They’re being detected, measured, and tracked throughout the human body. Whether they are contributing to chronic disease, inflammation, aging, or organ dysfunction is still unknown, but this stage of research is building the foundation for what comes next.
What we can do now is stay aware, support ongoing research, and make realistic efforts to reduce exposure where possible. Knowledge will continue to evolve, and with it, hopefully clarity.
Detection of microplastics in human tissues and organs: A scoping review
